Chia-Ning Shen

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 13

Top Venues

Nature cancer

Cancers

Scientific reports

Nature communications

Academia Sinica

University of Bath (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Academia Sinica Jun 01 2013

Taiwan

Deputy Director :: Genomics Research Center

Academia Sinica Feb 01 2013

Taiwan

Associate Research Fellow :: Genomics Research Center

Academia Sinica Jul 13 2004 - Jan 31 2013

Taiwan

Assistant Research Fellow :: Genomics Research Center

University of Bath Feb 01 2002 - Jul 31 2004

United Kingdom

Research Officer :: Centre for Regenerative Medicine

Education History

University of Bath Dec 01 1998 - May 31 2002

United Kingdom

PHD :: Biology and Biochemistry

Publications

Yu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, Juan-Cheng Yang, Yang-Chang Wu, Heng-Hsiung Wu, Chia-Chien Lo, Chih-Ying Hsieh, Sze-Ching Wong, Chih-Hao Lu, Wan-Ling Wu, Shih-Jen Liu, Yi-Chuan Li, Ching-Chan Lin, Chia-Ning Shen, Mien-Chie Hung, Jaw-Town Lin, Chun-Chieh Yeh, Yuh-Pyng Sher
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy. Nature cancer 5 (3) (2024)
Yu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, Juan-Cheng Yang, Yang-Chang Wu, Heng-Hsiung Wu, Chia-Chien Lo, Chih-Ying Hsieh, Sze-Ching Wong, Chih-Hao Lu, Wan-Ling Wu, Shih-Jen Liu, Yi-Chuan Li, Ching-Chan Lin, Chia-Ning Shen, Mien-Chie Hung, Jaw-Town Lin, Chun-Chieh Yeh, Yuh-Pyng Sher
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy. Nature cancer (2024)
Yu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, Juan-Cheng Yang, Yang-Chang Wu, Heng-Hsiung Wu, Chia-Chien Lo, Chih-Ying Hsieh, Sze-Ching Wong, Chih-Hao Lu, Wan-Ling Wu, Shih-Jen Liu, Yi-Chuan Li, Ching-Chan Lin, Chia-Ning Shen, Mien-Chie Hung, Jaw-Town Lin, Chun-Chieh Yeh, Yuh-Pyng Sher
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy. Nature cancer (2024)
Yu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, Juan-Cheng Yang, Yang-Chang Wu, Heng-Hsiung Wu, Chia-Chien Lo, Chih-Ying Hsieh, Sze-Ching Wong, Chih-Hao Lu, Wan-Ling Wu, Shih-Jen Liu, Yi-Chuan Li, Ching-Chan Lin, Chia-Ning Shen, Mien-Chie Hung, Jaw-Town Lin, Chun-Chieh Yeh, Yuh-Pyng Sher
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy. Nature cancer 5 (3) (2024)
Fu-Ting Hsiao, Hung-Jen Chien, Ya-Hsien Chou, Shih-Jung Peng, Mei-Hsin Chung, Tzu-Hui Huang, Li-Wen Lo, Chia-Ning Shen, Hsiu-Pi Chang, Chih-Yuan Lee, Chien-Chia Chen, Yung-Ming Jeng, Yun-Wen Tien, Shiue-Cheng Tang
Transparent tissue in solid state for solvent-free and antifade 3D imaging. Nature communications 14 (1) (2023)
Chih-Wei Lin, Yu-Jen Wang, Ting-Yen Lai, Tsui-Ling Hsu, Shin-Ying Han, Han-Chung Wu, Chia-Ning Shen, Van Dang, Ming-Wei Chen, Lan-Bo Chen, Chi-Huey Wong
Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 118 (50) (2022)
Fang-Chi Hsu, Hsin-Lun Lee, Yin-Ju Chen, Yao-An Shen, Yi-Chieh Tsai, Meng-Huang Wu, Chia-Chun Kuo, Long-Sheng Lu, Shauh-Der Yeh, Wen-Sheng Huang, Chia-Ning Shen, Jeng-Fong Chiou
A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions. Cancers 14 (2) (2022)
Heng-Hsiung Wu, Lung-Hung Tsai, Chun-Kai Huang, Pang-Hung Hsu, Mei-Yu Chen, Yi-Ing Chen, Chun-Mei Hu, Chia-Ning Shen, Chen-Chen Lee, Ming-Chu Chang, Yu-Ting Chang, Yun-Wen Tien, Yung-Ming Jeng, Eva Y-H P Lee, Wen-Hwa Lee
Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer. Science translational medicine 13 (583) (2021)
Hsin-Lun Lee, Jeng-Fong Chiou, Peng-Yuan Wang, Long-Sheng Lu, Chia-Ning Shen, Han-Lin Hsu, Thierry Burnouf, Lai-Lei Ting, Pai-Chien Chou, Chi-Li Chung, Kai-Ling Lee, Her-Shyong Shiah, Yen-Lin Liu, Yin-Ju Chen
Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer. Cancers 12 (11) (2020)
Janaki N Sudhakar, Hsueh-Han Lu, Hung-Yu Chiang, Ching-Shu Suen, Ming-Jing Hwang, Sung-Yu Wu, Chia-Ning Shen, Yao-Ming Chang, Fu-An Li, Fu-Tong Liu, Jr-Wen Shui
Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas. Nature communications 11 (1) (2020)
Yu-Tsen Lin, Cheng-Kai Wang, Shang-Chih Yang, Shu-Ching Hsu, Hsuan Lin, Fang-Pei Chang, Tzu-Chien Kuo, Chia-Ning Shen, Po-Ming Chiang, Michael Hsiao, Frank Leigh Lu, Jean Lu
Elimination of undifferentiated human embryonic stem cells by cardiac glycosides. Scientific reports 7 (1) (2017)
Chia-Ling Hsieh, Che-Ming Liu, Hsin-An Chen, Shun-Tai Yang, Katsumi Shigemura, Koichi Kitagawa, Fukashi Yamamichi, Masato Fujisawa, Yun-Ru Liu, Wei-Hua Lee, Kuan-Chou Chen, Chia-Ning Shen, Cheng-Chieh Lin, Leland W K Chung, Shian-Ying Sung
Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression. Scientific reports 7 (1) (2017)
Hsiao-Min Chang, Wen-Yen Huang, Sung-Jan Lin, Wei-Chao Huang, Chia-Rui Shen, Wan-Yu Mao, Chia-Ning Shen
ABCG2 deficiency in skin impairs re-epithelialization in cutaneous wound healing. Experimental dermatology 25 (5) (2016)

Chia-Ning Shen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chia-Ning Shen